Uncategorized Archives - Page 40 of 249

WednesdayJun 01, 2022 12:00 pm

CWCB Expo Arrives in New York To Offer Greater Networking and Business Opportunities In The Cannabis Sector

CWCB Expo is a leading B2B marketplace for networking within the cannabis community. Become a part of the interactive educational sessions, hold unique product displays, participate in panel discussions, and seek the phenomenal opportunities offered by the CWCB platform. The conference is being held on June 2-4, 2022 as an in-person event for the hemp and cannabis business community in New York. From discovering the more creative products being showcased to making launch announcements, the CWCBExpo is the center place of all cannabis business. Industry thought leaders and eminent personas of the cannabis arena from New York and around the…

WednesdayJun 01, 2022 11:15 am

With a Focus on Accountability, Prime Harvest Inc. Continues to Grow as a Leader in California’s Cannabis Industry

Prime Harvest is a California-based tech-driven full-service cannabis corporation focused on direct-to-consumer operations, licensing acquisition, compliance management, and state-wide delivery Prime Harvest fuses integrity into operations, dedicated to redefining the customer experience, being a force for good within the communities they serve, while building a valuable enterprise Member of Community Alliance Program (“CAP”), supports education, arts initiatives, and military veteran organizations in local Southern California Company launched Jaxx Cannabis in 2019, sales increased by 34% in early 2020, hit record 63% gross margin in Q1-2020 From its humble beginnings in 2017 as a cannabis producer in San Diego, Prime Harvest,…

WednesdayJun 01, 2022 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Consistently Enhancing the Oral Administration of Active Pharmaceutical Ingredients

A global innovator in drug delivery platforms, Lexaria has developed a patented technology, DehydraTECH(TM) Through research, Lexaria has evidenced that DehydraTECH enhances the efficiency and speed of orally- administered fat-soluble active pharmaceutical ingredients (“APIs”) Lexaria is consistently enhancing the delivery of APIs that affect current oral formulations: speed of onset, limited absorption, and low membrane permeability Lexaria has conducted numerous ground-breaking studies, some of which open up the possibility of fast-acting oral products that avoid the lung diseases and cancers caused by inhalation of combusted molecules common in smoking Oral formulations account for approximately 90% of the global share of…

TuesdayMay 31, 2022 12:00 pm

CWCBExpo, the Premier B2B Cannabis, and Hemp Expo and Conference to Foster Lively Discussion on Industry Opportunities and Challenges Among Seasoned Professionals and Newcomers Alike

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held between June 2-4, 2022, at the Javits Convention Center, Hall 3A, in New York City. Industry heavyweights, the foremost innovators, and pioneering thought leaders will take the stage to discuss emerging trends in cannabis, hemp, and allied sectors. The expo will provide a high-quality business-focused attendee base located in the premier East Coast US cannabis and hemp market. The three-day event will feature an Inside the Industry: Thought Leadership Series in an interactive “Talk Show” format. Co-hosts will include Carl Cameron, veteran journalist and former FOX News reporter; Faye…

FridayMay 27, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging Growing Commercial Opportunities

Lexaria is a biotechnology company focused on licensing its proprietary DehydraTECH(TM) technology The DehydraTECH technology has been proven to increase the bioavailability, speed of onset and brain absorption of APIs, and improve customer experiences by masking unwanted tastes Lexaria has 25 patents granted worldwide and is pursuing numerous other pending patent applications The company operates several subsidiary companies to focus on different commercial opportunities Ever since acquiring its first intellectual property (“IP”) that subsequently formed the basis of its first two patent application filings in 2014, biotechnology company Lexaria Bioscience (NASDAQ: LEXX) has grown the number of patents granted and…

ThursdayMay 26, 2022 12:00 pm

The Cannabis World Congress & Business Exposition (‘CWCBExpo’) is the Pre-eminent Forum for Gaining a Foothold Within New York’s Fast-Accelerating Cannabis Sector

New York’s recreational and medical marijuana market is poised for historical growth amid rising public and political support for increased cultivation in the tri-state area. The Cannabis World Congress & Business Exposition (“CWCBExpo”), set to take place at New York City’s Javits Convention Center, Hall 3A on June 2-4, 2022, is the ideal forum for exploring industry best practices, business building and networking within this dynamic sector industry. In September 2021, adult New Yorkers could legally possess up to three ounces of cannabis for recreational use or up to 24 grams of concentrated cannabis in certain products such as oils. With…

WednesdayMay 25, 2022 11:15 am

Flora Growth Corp. (NASDAQ: FLGC) Increases Vessel’s Footprint in the Canadian Cannabis Marketplace; Expands Its Operational Footprint in the E.U. and UK

Flora Growth’s Vessel brand just got listed on the Ontario Cannabis Store (“OCS”) Vessel also launched its direct-to-consumer online store to take control of its customer relationship journey Flora, through this expansion, seeks to tap into the growing Canadian cannabis market, which is valued at an estimated CAD 5.9 billion in 2022 The company has also expanded its operational footprint in Europe and the U.K. in a move that furthers its international growth strategy Flora Growth (NASDAQ: FLGC) just announced that its Vessel brand just got listed on the Ontario Cannabis Store (“OCS”) in a move that significantly increases the…

WednesdayMay 25, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Making Waves in the Growing Antiviral Drug Space with its DehydraTECH Technology

Lexaria Bioscience Corp., through its patented DehydraTECH technology, is improving the way many drugs enter the bloodstream In June 2021, the company proved that an antiviral drug enhanced with its technology was effective at inhibiting the COVID-19/SARS-CoV-2 virus With the global antiviral market projected to hit $66.7 billion by 2025, Lexaria plans to capitalize on this growth by pushing its DehydraTECH technology and exploring multiple avenues of related application Today, it is estimated that infectious diseases account for a quarter to one-third of mortality globally. This has mainly been attributed to increased travel, globalization, populated cities, urbanization, and changes in…

TuesdayMay 24, 2022 12:00 pm

The Flagship CWCBExpo of the New York Cannabis Week to be Held June 2-4; Will Foster Relationships Among Hundreds of Business Leaders from Across the Cannabis Ecosystem

The Cannabis World Congress & Business Exposition (“CWCBExpo”) will be held in New York City between June 2-4, 2022 The conference will feature dozens of expert speakers with expertise in developing brands, increasing efficiencies, and investments Hundreds of exhibitors and leading cannabis businesses will showcase cutting-edge product innovations In 2021, revenue from licensed marijuana of $24.5bn – $27bn in the United States eclipsed Starbucks sales throughout North America The Cannabis World Congress & Business Exposition (“CWCBExpo”) event will be held at New York City’s Javits Convention Center, Hall 3A on June 2-4, 2022. As the flagship event during Cannabis Week, a platform…

MondayMay 23, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Year-end Report Shows Significant Revenue and Profit Growth, with Expectations for Further Rapid Growth in 2022

Cannabis cultivator and distributor Flora Growth has announced its annual financial and operating results, showing “significantly higher” revenues and profit gain for 2021 over the previous year Flora maintains an outlook for 2022 of an additional 288 to 400 percent revenue growth by year end, largely driven by the company’s acquisition of consumer wellness brand JustCBD The JustCBD acquisition increased Flora’s reach to more than half a million consumers through 14,000 retail stores in the United States Flora’s operations are centered at its Cosechemos cultivation facility in central Colombia, where the company enjoys ideal growing conditions year-round and has easy…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized